Back to Trades
Smither John W
InsiderCIK 0001559583
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 4
- Active
- 2025–2026
Smither John W accounts for 7 disclosed filings worth $8.6M, spread across 4 companies, active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $75.4K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Sep 9 | NAMS NewAmsterdam Pharma Co N.V. | Smither John W | Insider | Sell | $40.5K |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Smither John W | Insider | Other | $0 |
| Aug 4 | MBX MBX Biosciences, Inc. | Smither John W | Insider | Grant | $8.4M |
| Jul 2 | GNLX GENELUX Corp | Smither John W | Director | Sell | $34.9K |
| Jun 18 | GNLX GENELUX Corp | Smither John W | Director | Grant | $95.6K |
| Mar 18 | MBX MBX Biosciences, Inc. | Smither John W | Insider | Other | $0 |
| Aug 29 | GNLX GENELUX Corp | Smither John W | Director | Grant | $104.0K |
7 filings